Cargando…
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung carcinoma (NSCLC) subtype. Despite the increased screening efforts, the median five-year survival of metastatic NSCLC remains...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858415/ https://www.ncbi.nlm.nih.gov/pubmed/36661704 http://dx.doi.org/10.3390/curroncol30010055 |